- Home
- SSSS vs PROF Comparison
SSSS vs PROF Comparison
Compare SSSS & PROF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | SSSS | PROF |
|---|---|---|
| Founded | 2010 | N/A |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Finance: Consumer Services | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 232.4M | 230.4M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | SSSS | PROF |
|---|---|---|
| Price | $9.46 | $8.17 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 4 | 1 |
| Target Price | $10.13 | ★ $11.00 |
| AVG Volume (30 Days) | 137.4K | ★ 175.6K |
| Earning Date | 11-04-2025 | 11-13-2025 |
| Dividend Yield | ★ 10.21% | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 2.61 | N/A |
| Revenue | $2,354,933.00 | ★ $14,297,000.00 |
| Revenue This Year | $7,183.09 | $64.23 |
| Revenue Next Year | N/A | $113.06 |
| P/E Ratio | $3.76 | ★ N/A |
| Revenue Growth | N/A | ★ 67.94 |
| 52 Week Low | $4.21 | $3.76 |
| 52 Week High | $10.34 | $7.99 |
Technical Indicators
Market Signals| Indicator | SSSS | PROF |
|---|---|---|
| Relative Strength Index (RSI) | 50.07 | 68.01 |
| Support Level | $9.17 | $7.33 |
| Resistance Level | $9.92 | $7.99 |
| Average True Range (ATR) | 0.27 | 0.45 |
| MACD | 0.03 | 0.01 |
| Stochastic Oscillator | 51.16 | 90.80 |
Price Performance
Historical ComparisonAbout SSSS SuRo Capital Corp.
SuRo Capital Corp is a non-diversified closed-end management investment company. The company's investment objective is to maximize its portfolio's total return, principally by seeking capital gains on its equity and equity-related investments.
About PROF Profound Medical Corp.
Profound Medical Corp is a commercial-stage medical device company focused on the development and marketing of customizable, incision-free therapeutic systems for the image-guided ablation of diseased tissue utilizing its platform technologies and leveraging the healthcare system's existing imaging infrastructure. The company's product TULSA-PRO system combines real-time MRI, robotically driven transurethral sweeping-action thermal ultrasound with closed-loop temperature feedback control for the ablation of prostate tissue. The product is comprised of one-time-use devices and durable equipment that are used in conjunction with a customer's existing MRI scanner.